Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes

NCT04374578 · Completed

Last updated 2026-05-28

This clinical trial tested the effect of dulaglutide on blood sugar fluctuations in adults with type 2 diabetes.

Status Completed The study has finished.

Type Observational

Participants 100 people

Who can join Ages 18–70 · all sexes

Timeline Started 2020-05 · est. completion 2021-06

Where 1 site · China

What this study is testing ClinicalTrials.gov NCT04374578 ↗

Description as written by the study sponsor.

Glycemic variability will be assessed using continuous glucose monitor(CGM) in type 2 diabetic patients who receive dulaglutide 1.5 mg/qw injection for 4 weeks.

Treatments tested

Dulaglutide 1.5 MG/ML Drug

Dulaglutide 1.5Mg qw sc injection for 4 weeks

Main thing measured	Effect on glycemic variability
Sponsor	Shanghai Zhongshan Hospital
Conditions studied	Type 2 Diabetes
GLP-1 drugs	dulaglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT04374578 ↗